MedReleaf Corp (LEAF) Given a C$15.00 Price Target by Canaccord Genuity Analysts

MedReleaf Corp (TSE:LEAF) received a C$15.00 target price from equities research analysts at Canaccord Genuity in a report released on Thursday. The firm currently has a “speculative buy” rating on the stock. Canaccord Genuity’s price target suggests a potential upside of 16.64% from the company’s current price.

WARNING: This piece was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at https://www.com-unik.info/2017/11/02/medreleaf-corp-leaf-given-a-c15-00-price-target-by-canaccord-genuity-analysts.html.

In other news, insider Stephen Arbib sold 10,000 shares of MedReleaf Corp stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of C$8.10, for a total value of C$81,000.00.

About MedReleaf Corp

What are top analysts saying about MedReleaf Corp? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MedReleaf Corp and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit